No Data
Financial Survey: Revolution Medicines (NASDAQ:RVMD) and Opthea (NASDAQ:OPT)
Revolution Medicines (NASDAQ:RVMD – Get Rating) and Opthea (NASDAQ:OPT – Get Rating) are both medical companies, but which is the better stock? We will compare the two companies based on the strength
Opthea Announces Presentation at H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference
Globe Newswire 16-Aug-2022 7:46 AMMELBOURNE, Australia, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Opthea Limited ((ASX:OPT, NASDAQ:OPT), a clinical stage biopharmaceutical company developing novel therapie
Opthea receives $170M in non-dilutive financing for OPT-302 in wet AMD
Opthea (NASDAQ:OPT) entered into a non-dilutive financing transaction for up to $170M from investment funds working with Launch Therapeutics to finance and advance the ongoing Phase 3 clinical trials
Opthea Secures Up To US$170 Mln In Financing For OPT-302 In Wet AMD
Opthea Limited (OPT, OPT.AX) said that it has secured up to US$170 million in non-dilutive financing to advance the ongoing phase 3 clinical trials and pre-commercialization activities of OPT-302 for
Press Release: Opthea Successfully Closes Well Supported US$90 Million Equity Financing
Opthea Successfully Closes Well Supported US$90 Million Equity Financing MELBOURNE, Australia, Aug. 14, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; NASDAQ: OPT) (Opthea), a clinical stage bioph
Press Release: Opthea Successfully Closes Well -2-
In particular, this ASX announcement does not constitute an offer to sell, or a solicitation of any offer to buy, any securities in the United States or any other jurisdiction in which such an offer w
Press Release: Opthea Secures up to US$170 -2-
Carlyle (NASDAQ: CG) is a global investment firm with deep industry expertise that deploys private capital across three business segments: Global Private Equity, Global Credit and Global Investment So
Optiva Q2 Adjusted EPS Loss US$0.11 Vs Loss US$0.03 Year Ago; Revenue Falls
06:31 AM EDT, 08/10/2022 (MT Newswires) -- Optiva (OPT.TO), a provider of revenue management software for the telecommunications industry, overnight Tuesday reported Q2 adjusted EPS loss of US$0.11 ve
Earnings Scheduled For August 9, 2022
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter. • Gilat Satellite Networks (NASDAQ:GILT) is estimated to report quart
Opthea (NASDAQ:OPT) Shares Up 3.4%
Opthea Limited (NASDAQ:OPT – Get Rating)'s stock price shot up 3.4% during trading on Tuesday . The company traded as high as $7.00 and last traded at $7.00. 691 shares traded hands during trading, a
